Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Benzbromarone-Controlled, Double-Blind, Comparative Study of FYU-981 for Hyperuricemia With or Without Gout to Evaluate the Safety and Noninferiority of FYU-981 (Phase III Study)

NCT03100318 is registered in ClinicalTrials.gov with Fuji Yakuhin Co., Ltd. as lead sponsor.

NCT NCT03100318
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03100318 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Benzbromarone-Controlled, Double-Blind, Comparative Study of FYU-981 for Hyperuricemia With or Without Gout to Evaluate the Safety and Noninferiority of FYU-981 (Phase III Study)
Lead sponsor
Fuji Yakuhin Co., Ltd.
Phase
Phase 3
Overall status
Completed
Start date
April 1, 2017
Completion date
August 31, 2018
Enrollment
201 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperuricemia with or without gout